MacuMira Treatment for Dry AMD

Effortless integration, comprehensive device training, & enhanced support for delivering dry AMD care.

Book Now

MacuMira: Help Your Patients See What’s Possible

Dry age-related macular degeneration (AMD) has traditionally been managed with lifestyle recommendations and supplements. But now, with MacuMira, your clinic can offer more than monitoring—you can offer measurable improvement.

With MacuMira, you finally have a solution. You can provide real help instead of just hope.

MacuMira is a noninvasive, in-office therapy that delivers low-level microcurrent stimulation through the eyelids to support retinal function. Clinically proven to improve visual acuity and contrast sensitivity, this Australian- and New Zealand-available treatment provides providers with a new tool for patient care.

All MacuMira providers receive hands-on training, comprehensive support, and easy-to-follow treatment protocols. Whether you’re ready to integrate now or want to learn more, we’re here to help.

How MacuMira Works in Practice

Training & Onboarding

We offer a half-day, in-person training session with a certified MacuMira educator. After this session, your team should be fully prepared to deliver safe, effective treatment.

Seamless Integration for Your Practice

MacuMira is designed to integrate smoothly into your existing patient flow. With straightforward protocols and intuitive operation, your team can get up to speed quickly, whether or not they have experience with similar technologies.

Microcurrent Stimulation

MacuMira uses Microcurrent Stimulation to support retinal health. It’s the first and only treatment of its kind for dry AMD, built on technology that has been safely used for decades.

Patented Waveform & Delivery

MacuMira’s patented microcurrent stimulation was developed to maximise therapeutic efficacy.  Our intuitive user interface is straightforward for a technician to operate.

Retinal Rejuvenation

MacuMira’s stimulation of RPE cells enhances mitochondrial ATP formation, leading to improved cellular function.

Ongoing Results

Patients often have noticeable improvement in visual function after the initial 10-day loading phase (4 x 32-minute sessions). These improvements can be maintained with treatment every 3 months.

Become a MacuMira Provider

MacuMira is helping clinics across Australia and New Zealand offer new hope to patients with dry AMD. With simple onboarding and full support, you can easily integrate this evidence-based treatment into your practice.

MacuMira providers receive comprehensive training from our team to support the successful implementation of your devices. Our mission is to enhance the vision and quality of life for people worldwide living with dry AMD, and we’d appreciate your help.

By becoming a provider, you can help change the trajectory of this common, progressive eye disease. Whether you are exploring your options or ready to integrate MacuMira into your clinic, our team will support you every step of the way.

What MacuMira Providers are Saying

Rethinking What’s Possible for Dry AMD

What if central vision loss were no longer the expected outcome for patients with dry AMD? At MacuMira, we believe in changing the trajectory of this condition through safe, effective treatment options.

If you would like to learn more about bringing MacuMira to your clinic, access clinical research, explore patient communication tools, or speak with our team, simply complete the form below.

Articles

Understanding how dry AMD affects you or your family member can make it a little easier to navigate. Learn more about this eye disease in our articles.

instagram facebook facebook2 pinterest twitter google-plus google linkedin2 yelp youtube phone location calendar share2 link star-full star star-half chevron-right chevron-left chevron-down chevron-up envelope fax